Published on January 17, 2023 – 13:09 GMT
Bridge Therapeutics Predicts Better Management of Opioid Use Disorder through the MAT Act
Further Advances in Sight, Especially for Rural and Minority Communities NEW YORK, NY, UNITED STATES, January 17, 2023 /EINPresswire.com/ — NBridge Therapeutics, a late-stage development company, today said that the MAT Act removes the outdated …
Distribution channels: Banking, Finance & Investment Industry, Emergency Services …
